Navigation Links
Amylin Pharmaceuticals Reports Third Quarter Financial Results
Date:10/19/2011

showed exenatide, at and above therapeutic levels, did not prolong the corrected QT interval in healthy individuals
  • Announced that the FDA assigned a new Prescription Drug User Fee Act (PDUFA) action date of January 28, 2012 for BYDUREON
  • Presented compelling efficacy and safety data at the European Association for the Study of Diabetes (EASD) Annual Meeting from the DURATION-3 and -4 trials. The studies demonstrated that patients treated with BYDUREON experienced significant improvements in select cardiovascular risk factors, including improvements in composite endpoints related to body weight, abnormal blood pressure and abnormal lipid levels, in comparison to patients who received commonly prescribed diabetes treatments

  • Obesity Program

  • Announced the discontinuation of the pramlintide/metreleptin development program for obesity. The joint decision between Amylin and Takeda Pharmaceuticals Limited was based on a commercial reassessment of the pramlintide/metreleption program. The companies continue to evaluate other assets as potential candidates for the treatment of obesity and related indications under the terms of their existing collaboration agreement

  • Quarter Ended September 30, 2011Net product sales of $155.1 million for the quarter ended September 30, 2011 include $128.1 million for BYETTA® (exenatide) injection and $27.0 million for SYMLIN® (pramlintide acetate) injection. This compares to net product sales of $154.0 million, consisting of $132.4 million for BYETTA and $21.6 million for SYMLIN for the same period in 2010. Revenues under collaborative agreements were $19.9 million for the quarter ended September 30, 2011, and included a $15.0 million milestone payment from Lilly in connection with the launch of BYDUREON in the European Union in July, compared to $2.1 million for the same period in 2010.

    Selling, general and administrative expenses decreased to $63.1 million for the q
    '/>"/>

    SOURCE Amylin Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Amylin Pharmaceuticals to Webcast Third Quarter Results
    2. Amylin Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
    3. Amylin and Takeda Discontinue Development of Pramlintide/Metreleptin Combination Treatment for Obesity Following Commercial Reassessment of the Program
    4. Amylin Pharmaceuticals to Webcast Second Quarter Results
    5. U.S. District Court Rules in Favor of Lilly in Amylin Litigation
    6. Amylin Pharmaceuticals Issues Statement Regarding U.S. District Court Order
    7. Amylin Pharmaceuticals Obtains Temporary Restraining Order Against Eli Lilly
    8. Lilly Comments on Court Ruling in Amylin Litigation
    9. Amylin Pharmaceuticals to Present at Annual Meeting of Stockholders
    10. Lilly Provides Its Perspective in Response to Amylin Lawsuit
    11. Lilly Provides Statement in Response to Amylin Lawsuit
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/20/2014)... , Aug. 20, 2014  The National Association ... latest results achieved by the real-time, pseudoephedrine (PSE) ... National Precursor Log Exchange (NPLEx), automatically blocks unlawful ... down methamphetamine offenders and make arrests. Data released ... Missouri blocked the sale of more ...
    (Date:8/20/2014)... 20, 2014 Reportlinker.com announces that a ... catalogue: The Impact of Healthcare Reform ... http://www.reportlinker.com/p01618927/The-Impact-of-Healthcare-Reform-PPACA-On-the-US-IVD-Industry.html The "Patient ... complex legislation that affects virtually every aspect of ... beginning to take effect now. IVD manufacturers who ...
    (Date:8/20/2014)... , Aug. 20, 2014 Reportbuyer.com has ... Cardiac Defibrillators Industry https://www.reportbuyer.com/product/98394/Global-Cardiac-Defibrillators-Industry.html ... Defibrillators in US$ Million by the following Product Segments: ... separate comprehensive analytics for the US, Canada ... Europe , Asia-Pacific , ...
    Breaking Medicine Technology:Missouri's Stop-Sale System Achieves Significant Results In Battle Against Meth 2The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 2The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 3The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 4The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 5The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 6Global Cardiac Defibrillators Industry 2Global Cardiac Defibrillators Industry 3Global Cardiac Defibrillators Industry 4Global Cardiac Defibrillators Industry 5Global Cardiac Defibrillators Industry 6Global Cardiac Defibrillators Industry 7Global Cardiac Defibrillators Industry 8Global Cardiac Defibrillators Industry 9Global Cardiac Defibrillators Industry 10Global Cardiac Defibrillators Industry 11Global Cardiac Defibrillators Industry 12Global Cardiac Defibrillators Industry 13Global Cardiac Defibrillators Industry 14Global Cardiac Defibrillators Industry 15Global Cardiac Defibrillators Industry 16Global Cardiac Defibrillators Industry 17Global Cardiac Defibrillators Industry 18Global Cardiac Defibrillators Industry 19Global Cardiac Defibrillators Industry 20
    ... Prometheus Laboratories Inc., a specialty pharmaceutical and ... of three new cancer diagnostic products: ProOnc TumorSource ... Each of these tests is based on recently ... a long and successful history of providing innovative ...
    ... Mylan Inc. (Nasdaq: MYL ) today announced that ... the U.S. Food and Drug Administration (FDA) for its ... 15 mg and 25 mg. , Topiramate Capsules (Sprinkle) ... Sprinkle Capsules, 15 mg and 25 mg. For the ...
    Cached Medicine Technology:Prometheus Launches ProOnc Dx Cancer Diagnostics 2Prometheus Launches ProOnc Dx Cancer Diagnostics 3
    (Date:8/21/2014)... 21, 2014 OpsAssure, the local ... selected to participate in the Harbor Accelerator's 14 ... curriculum sessions and valuable resources.he Harbor’s goal is ... region. Each start-up selected for the program receives ... to help businesses grow quickly, test markets and ...
    (Date:8/21/2014)... Recently, BambooIndustry.com, one of the most famous ... new range of hand scraped bamboo floorings ... an Autumn special offer for these elegant items. According ... a discounted price, up to 25% off; the promotion ... , Providing natural looks and available in different varieties, ...
    (Date:8/20/2014)... 2014 On September 7th, 2014 Peoria will ... connects people living with MS with people who care. This ... are 85% of the way to their goal. This years ... at 11:30 and the walk starts at 1:00 pm. ... answer question about chiropractic care and how it helps symptoms ...
    (Date:8/20/2014)... Los Angeles, CA (PRWEB) August 21, 2014 ... that features in-depth information and reviews of some of ... and many others, is pleased to announce that it ... of the systems. For seniors who are on a ... of medical device, this announcement comes as very welcome ...
    (Date:8/20/2014)... UWDress.com, the distinguished wedding dress manufacturer and retailer, has ... for girls . According to the company’s marketing specialist, ... experienced specialists. Now, they are provided with discounted prices, ... items come in various styles: A-line scalloped edge gowns, ... backless gowns and so on. It is working hard ...
    Breaking Medicine News(10 mins):Health News:Cheap Hand Scraped Bamboo Floorings Recently Unveiled by BambooIndustry.com 2Health News:Dr. Kelch of AlignLife North Peoria Supports Peoria Annual Walk MS 2Health News:Medical Alert Systems Website Now Offering Special Prices on the Popular Medical Guardian Product 2Health News:Medical Alert Systems Website Now Offering Special Prices on the Popular Medical Guardian Product 3Health News:Cheap Birthday Party Dresses for Girls Now Available at UWDress.com 2
    ... Forest University Baptist Medical Center have found out that ... in people with diastolic heart failure, suggesting other potential ... ,'Reduced tolerance for physical activity is the primary ... quality of life,' said Dalane Kitzman, M.D., professor of ...
    ... Experts from Imperial College London UK opine that new measures ... //Even after mammoth efforts for comprehensive immunization from the health ... happen to be from India. ,According to ... polio in India are due to improper sanitation and congestion ...
    ... Programme of Nutritional Support to Primary Education (commonly known ... nutritional programme in the world //covering nearly 12 crore ... Scheme (EGS)/Alternative and Innovative Education (AIE) centers. ... minimum 450 calories and 12 gms of protein. The ...
    ... senator, announced on Thursday that he proposed to introduce ... // ,The bill is better known as "Texas ... other public places would be banned under legislation. ,Ellis made ... the American Cancer Society's Great American Smokeout. ,"Even ...
    ... wine has contributed to the health ratings of the famous ... laden diets in much the same way as mice on ... earlier study conducted by Harvard Scientists. ,Delving more ... uncorked additional blessings, following a second study conducted on mice. ...
    ... that both diet and exercise works well for weight loss, ... further suggests those who want to lose weight in their ... room instead of counting calories. ,Both, those who ... weight, according to findings from the study on ‘whether a ...
    Cached Medicine News:Health News:Exercise Intolerance In Heart Failure Patients Is Explored By Researchers 2Health News:Exercise Intolerance In Heart Failure Patients Is Explored By Researchers 3Health News:Polio can be eradicated in India: Health Experts 2Health News:Mid-Day Meal Scheme Catches on in India 2Health News:Which Is Better For Losing Weight? - Diet Or Exercise 2
    ... technology developed over Guidants 20-year history, the ... foundation for successful treatment outcomes. It combines ... with a lower profile shaft,more flexible markers, ... can cross tight and tortuous anatomy with ...
    ... technology developed over Guidants 20-year history, the ... foundation for successful treatment outcomes. It combines ... with a lower profile shaft,more flexible markers, ... can cross tight and tortuous anatomy with ...
    Abbott offers an array of both in-vitro and molecular diagnostic tests for the detection and monitoring of cancerous conditions in patients....
    Abbott offers an array of both in-vitro and molecular diagnostic tests for the detection and monitoring of cancerous conditions in patients....
    Medicine Products: